Anti‐PD1 monoclonal antibodies vs chemotherapy alone
Tumour response · people with cutaneous melanoma
Anti‐PD1 monoclonal antibodies leads to higher tumour response compared with chemotherapy (high certainty).
1 finding from 1 review
- RR 3.42 [2.38, 4.92]1367 participantsHigh